the rise consortium betafat study | john wilding
Published 5 years ago • 21 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
2:13
expert commentary: the rise study | john wilding
-
3:38
expert commentary: the rewind trial | john wilding
-
0:38
clinical takeaway: the carolina trial | john wilding
-
22:08
how was it for you? the experts discuss easd 2019 | john wilding, amrit lamba, and lori berard
-
2:44
expert commentary: the harmony trial | john wilding
-
14:06
sglt2 inhibitors: the story so far | john wilding
-
3:44
sglt2 inhibition in type 1 diabetes patients | john wilding
-
2:18
expert commentary: trials of imeglimin in type 2 diabetes | john wilding
-
1:54
the updated diabetes uk nutrition guidelines: an obesity specialist’s view | john wilding
-
5:50
researcher comment: declare-timi 58 | john wilding
-
4:18
expert commentary: the 2-year direct outcomes | john wilding
-
3:19
expert highlights: high-performance exercise and type 1 diabetes | john wilding
-
9:12
diabetic retinopathy: pathogenesis | philip burgess & john wilding
-
9:44
uk nutrition guidelines: a fresh approach | john wilding & pamela dyson
-
10:11
diabetic retinopathy: treatment | philip burgess & john wilding
-
10:01
diabetic retinopathy: screening | philip burgess & john wilding
-
3:58
ada 2021 – the surpass trials so far: tirzepatide, semaglutide, and type 2 diabetes | john wilding
-
3:41
expert commentary: the preview project | amrit lamba